Company Description
Aurora Cannabis Inc., together with its subsidiaries, engages in the production, distribution, and sale of cannabis and cannabis-derivative products in Canada and internationally.
It operates through two segments, Canadian Cannabis and Plant Propagation. The company offers medical and consumer cannabis products; supplies propagated vegetables and ornamental plants; and distributes and sells hemp-derived cannabidiol (CBD) products.
The company also cultivates and sells dried cannabis, cannabis oils, capsules, edible cannabis, cannabis extracts, and soft gels, which are ingested in various ways, including smoking, vaporizing, and consumption in the form of oil, capsules, dried flowers, vapes, dried milled strains, edibles, concentrates, and strain specific cannabis oils and extracts; and provides patient counseling and outreach services.
Its adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler, Being, and Greybeard, as well as CBD brands, Reliva and KG7; and medical cannabis brands include MedReleaf, CanniMed, Aurora, Whistler Medical Marijuana Co, Pedanios, Bidiol, and CraftPlant.
The company was founded in 2013 and is headquartered in Edmonton, Canada.
| Country | Canada |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 1,073 |
| CEO | Miguel Martin |
Contact Details
Address: 2207 90b Street Sw Edmonton, A0 T6X 1V8 Alberta, Canada | |
| Phone | 604-362-5207 |
| Website | auroramj.com |
Stock Details
| Ticker Symbol | ACB |
| Exchange | NASDAQ |
| Fiscal Year | April - March |
| Reporting Currency | CAD |
| CIK Code | 0001683541 |
| CUSIP Number | 05156X884 |
| ISIN Number | CA05156X8504 |
| SIC Code | 2833 |
Key Executives
| Name | Position |
|---|---|
| Miguel Martin | Chief Executive Officer and Director |
| Alex Miller | Executive Vice President of Operations and Supply Chain |
| Lori Schick | Executive Vice President of Human Resources |
| Andre Jerome | Executive Vice President of Global Business Development |
| Simona King | Chief Financial Officer |
| Ananth Krishnan | Vice President of Capital Markets and Investor Relations |
| Nathalie Clark | Executive Vice President, General Counsel and Corporate Secretary |
| Michelle Lefler | Vice President of Communications and Public Relations |
| Dr. Jonathan Page Ph.D. | Senior Science Advisor |
| Rick Savone | Senior Vice President of Global Government Relations |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Jul 11, 2024 | 6-K | Report of foreign issuer |
| Jul 9, 2024 | 6-K | Report of foreign issuer |
| Jul 5, 2024 | 6-K | Report of foreign issuer |
| Jun 20, 2024 | 6-K | Report of foreign issuer |
| Jun 20, 2024 | 40-F | Filing |
| Jun 7, 2024 | 6-K | Report of foreign issuer |
| May 28, 2024 | 6-K | Report of foreign issuer |
| May 22, 2024 | 6-K | Report of foreign issuer |
| May 14, 2024 | 6-K | Report of foreign issuer |
| May 1, 2024 | 6-K | Report of foreign issuer |